Abstract Aims: Information on the prevalence and clinical, electrocardiographic and echocardiographic inter-relationships of mechanical dyssynchrony among patients with heart failure (HF) and left ventricular systolic dysfunction derives mainly from relatively small studies. The CARE-HF trial provides the opportunity to address these issues in a large population of patients with advanced HF. Methods and results: The CARE-HF trial enrolled patients with New York Heart Association (NYHA) class III or IV HF, with a QRS duration !120 ms, left ventricular (LV) ejection fraction (EF) 35% and LV end diastolic diameter !30 mm/m (height in m). Patients underwent a thorough echocardiographic evaluation, which included assessment of LV structure, systolic function, mitral inflow pattern, right ventricular (RV) dimensions and function, and interventricular mechanical delay (IVMD) as an index of interventricular dyssynchrony. Echocardiographic measurements were made in a Core Laboratory to ensure consistent quantitative analysis.
Introduction
In patients with advanced heart failure (HF) and left bundle branch block, biventricular pacing improves cardiac function and clinical status. 1, 2 The rationale for biventricular stimulation is resynchronisation of mechanical dyssynchrony secondary to regional delays in electrical conduction. 3 However, QRS duration is known to be a relatively crude marker of ventricular dyssynchrony. Information on the prevalence of mechanical dyssynchrony among HF patients with prolonged QRS duration is sparse and the clinical, electrocardiographic and echocardiographic correlates of ventricular dyssynchrony were derived mainly from relatively small studies. 4e7 The CArdiac REsynchronisation Heart Failure (CARE-HF) trial provides the opportunity to address this issue in a large, representative population of patients with advanced HF. This paper describes the baseline echocardiographic characteristics of patients enrolled in the CARE-HF trial. The extent to which interventricular dyssynchrony is associated to QRS duration, the degree of left ventricular (LV) dysfunction and the aetiology of the disease (ischaemic vs nonischaemic) is evaluated.
Methods Patients
The CARE-HF trial enrolled patients with New York Heart Association (NYHA) class III or IV HF (despite undergoing optimal medical treatment), with a QRS duration !120 ms, LV ejection fraction (EF) 35%, LV end diastolic diameter !30 mm/m (height in m) 8 and in sinus rhythm. Patients with a QRS duration !150 ms did not require echo confirmation of dyssynchrony. Patients with a QRS duration between 120 and 149 ms required at least two of the following dyssynchrony criteria: (a) aortic pre-ejection delay >140 ms; (b) interventricular mechanical delay >40 ms; and (c) delayed activation of the posterolateral wall of the left ventricle as shown by any overlap between time from QRS to peak systolic movement of the posterior wall at M-mode and time from QRS to the beginning of the E-wave at pulsed Doppler transmitral flow.
Of the 813 patients enrolled in the trial, 735 had an analysable baseline echocardiographic examination and constitute the population described. The population included a subgroup of 92 patients with a QRS duration of between 120 and 149 ms measured in a Core Electrocardiographic Laboratory. Most of these patients (44/62) were enrolled after demonstrating dyssynchrony criteria a and b (described above).
Echocardiographic qualification
To participate in the CARE-HF trial, each centre had to go through a qualification procedure regarding accuracy and reproducibility of echocardiographic recordings. Meetings were held before the procedure to train the echocardiographers and a manual was prepared describing the echo protocol in detail. The trials were conducted in accordance with the Declaration of Helsinki.
Approval of a centre for inclusion in the CARE-HF trial was based on the assessment of videotapes submitted to the Echocardiographic Core Laboratory in Pavia, Italy. These included assessments of two patients, with one assessment being repeated within 24 h to assess reproducibility of results. In the event of an initial disqualification, the site was given at least one more opportunity to submit further recordings and/or readings for approval; 98% of the centres qualified at the first attempt.
Recording and analysis of echocardiographic examinations
Echocardiographic recordings were obtained with the use of commercially available instruments. In each patient, multiple views were recorded on Super VHS videotapes. All echocardiograms were sent to the Core Echo Laboratory to ensure consistent measurement methodology. Videotaped echocardiograms were analysed with specialized software for image processing. This enabled the image to be captured, digitalized, analysed and stored with the numerical data. Each variable was measured three times, and the average value calculated. All readings were made by qualified technicians and subsequently reviewed by a senior echocardiographer.
The recorded views and the variables measured or calculated are outlined in Table 1 . The enddiastolic (EDV) and end-systolic (ESV) volumes of the LV reported are those obtained using the Single Plane Area-Length method; EF was calculated as follows: (EDV ÿ ESV)/EDV Â 100. The degree of mitral regurgitation (MR) was assessed as the area of the colour flow Doppler regurgitant jet divided by the area of the left atrium in systole. Pulsed Doppler velocity signals of transmitral flow were recorded at 100 mm/s with the sample volume at the tips of the mitral valve leaflets. Peak velocities were measured during rapid LV filling (E-wave) and atrial contraction (A-wave), and the velocity ratio (E/A) was calculated. The deceleration time (DT) of the E-wave and the LV filling time were also measured; a DT <115 ms was considered indicative of a restrictive LV filling pattern. The trans-tricuspidal pressure gradient was obtained whenever feasible. The tricuspid annular plane systolic excursion (TAPSE) was used as an indicator of right ventricular (RV) function. Stroke volume was estimated as the product of the LV outflow tract velocity time integral and the cross-sectional area of the LV outflow tract. Pulsed-wave Doppler flow velocity signals were recorded from the RV and LV outflow tracts, and the aortic and pulmonary pre-ejection times were measured as the time intervals between the Q-wave on the surface ECG and the onset of flow. The interventricular mechanical delay (IVMD) was calculated as the time difference between the onset of forward flow in the LV (APET) and RV (PPET) outflow tracts: IVMD ¼ APET ÿ PPET. An IVMD >40 ms was considered indicative of interventricular dyssynchrony.
Measurement reproducibility in the Core Laboratory
Key echocardiographic variables were measured twice (at intervals of >1 week) in 25 patients with HF by two echo technicians, and adequate echocardiographic images were used to assess inter-and intra-observer variability. Agreement of measurements was calculated according to Bland and Altman. 9 As shown in Tables 2 and 3 , reproducibility was optimal even for a derived parameter such as EF.
Electrocardiograms were recorded at 50 mm/s in the majority of patients. Electrocardiographic intervals, including the QRS, were measured using hand-held calipers by two trained cardiology technicians.
Statistical analysis
Descriptive statistics were used to analyse the study population. A mixed model was developed in SAS statistical software (SAS ver. 9.1, SAS Institute Inc, Cary, NC) to account for the random effects associated with investigator sites. IVMD was used as the key index of dyssynchrony. APET is also an indicator of dyssynchrony, but is used to derive IVMD with which it is also co-linear. The linearity of potentially continuous predictors was examined by comparing the model fit in a stepwise manner with either the untransformed predictor, the log transformed predictor, or a restricted cubic spline with five knots. Proceeding to the next step only occurred once a statistically significant improvement in the model fit was achieved. 10 The multivariate model to predict IVMD was run both in the total population and following exclusion of the subgroup of patients with QRS duration below 150 ms (who were enrolled in the trial following echocardiographic demonstration of dyssynchrony [criteria specified earlier]). As the results of the analysis were similar, only data concerning the total population are presented.
Results
Eight hundred and three baseline tapes of echocardiographic images were received by the Core Laboratory; 68 (9%) were excluded from further analysis because of poor quality. Therefore, the study population consisted of 735 patients with a mean age of 65 years (IQR 59e72); 73% were male, 46% had ischaemic aetiology and QRS duration was 168 ms (IQR 155e180). There were 92 patients with a QRS duration <150 ms. Demographic and clinical characteristics were similar to those of the whole CARE-HF population.
11 Table 4 shows the baseline echocardiographic characteristics for the whole population. Of the 735 patients, 455 (62%) presented with interventricular dyssynchrony defined as IVMD >40 ms; QRS duration was 171 ms (IQR 160e180) in patients with IVMD >40 ms and 164 ms (IQR 152e174) in those with IVMD 40 ms (p < 0.0001). Table 4 shows the echocardiographic characteristics of the patients with (n ¼ 455) or without (n ¼ 280) interventricular dyssynchrony. Overall, the two groups were similar in terms of LV and RV function. The clinical, electrocardiographic and echocardiographic variables were then fitted in a multivariate model to identify factors independently associated with the degree of interventricular dyssynchrony (Table 5) . Heart failure cause, (log) QRS and mitral valve E/A ratio were all strongly associated with interventricular dyssynchrony, and (log) EF moderately so. However, the model provided only poor predictive information at the individual patient level, with a corrected R value of 0.11. Fig. 1 shows the uncorrected relationship between IVMD and QRS duration.
Discussion Baseline echocardiographic characteristics of the patients
The baseline echocardiographic data indicate that patients enrolled in the CARE-HF trial had advanced LV dysfunction similar to patients included in the MIRACLE trial. 12 However, the low percentage of patients with a restrictive mitral filling pattern, the minimal increase in trans-tricuspid pressure gradient, the normal mean RV diameter and normal TAPSE all suggest that few patients had end-stage disease characterized by pulmonary hypertension and RV dysfunction. Indeed, few patients in the trial were classified as NYHA functional class IV.
11
As has been observed in some previous smaller studies more than one-third of CARE-HF patients did not show interventricular dyssynchrony (280 out of 735 patients had an IVMD 40 ms) despite marked QRS prolongation. 6, 7 In this respect, the CARE-HF trial is ideally placed to determine whether the echocardiographic evaluation of interventricular dyssynchrony predicts the response to CRT and whether it is superior to QRS duration. A limitation of the study is the lack of data on intraventricular dyssynchrony but a three dimensional tissue Doppler imaging substudy has been conducted which may offer a new approach to the problem of predicting response to CRT.
Electrocardiographic and echocardiographic correlates of interventricular dyssynchrony
There was a linear relationship between the predictor variables and the outcome of interest. Although the interventricular delay was significantly related to QRS duration, the correlation observed was too poor to be clinically helpful and was worse than in previously reported populations. 6, 7 A reason for this may be that the CARE-HF trial recruited mostly patients with a markedly prolonged QRS duration (>150 ms) and those with intermediate QRS duration (of between 120 and 150 ms) were selected on the basis of echocardiographic evidence of dyssynchrony. In contrast, previous studies have enrolled patients with a wide range of QRS durations, including some with normal intraventricular conduction. It was hypothesized that other baseline characteristics of the patients could be used to identify those with interventricular dyssynchrony in addition to QRS duration. Non-ischaemic aetiology, LVEF, the mitral valve E/A ratio as well as QRS duration were predictive variables included in the final model. However, these variables were of limited practical value in identifying patients with IVMD >40 ms. Therefore, interventricular dyssynchrony in patients with HF may be considered an independent characteristic which is poorly related to any known clinical, electrocardiographic or echocardiographic variable. Indeed, classical left bundle branch block on the surface ECG may be due to diverse types of infranodal conduction abnormalities. The site of the delay in the conduction system (or ventricular myocardium) could be the most important factor in determining the degree of mechanical dyssynchrony. 13 
Conclusions
Patients enrolled in the CARE-HF trial were characterized by advanced LV dysfunction without echocardiographic evidence of pulmonary hypertension and RV dysfunction. In this population, the electrocardiographic, clinical and standard echocardiographic variables were of limited value in identifying those patients showing interventricular dyssynchrony (approximately two-thirds in total). It is concluded that, at present, a targeted echocardiographic evaluation is required to identify the presence of interventricular dyssynchrony in patients with advanced HF. Figure 1 Relationship between QRS duration and interventricular mechanical delay. The figure identifies the univariate relationship between increasing interventricular mechanical delay and QRS, which is plotted here on a log scale. The relationships between response variables including QRS and interventricular mechanical delay are described in Table 4 .
